Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026351331> ?p ?o ?g. }
- W2026351331 endingPage "2213" @default.
- W2026351331 startingPage "2207" @default.
- W2026351331 abstract "Objective: To evaluate clinical outcomes and the tolerability of 2 weeks' quetiapine (QTP) treatment for hospitalised patients in a naturalistic setting. Methods: Patients with schizophrenia (n = 18), drug-induced psychosis (n = 10; 3 cocaine, 4 hashish and marijuana, and 3 all three substances) or borderline personality disorder (n = 13), were diagnosed by two expert clinicians on the basis of an unstructured clinical interview, and were treated with QTP (250 – 1000 mg/day). The subjects were then clinically assessed at baseline, and after 7 and 15 days, using the Brief Psychiatric Rating Scale, the Positive and Negative Symptoms Scale (PANSS) and the Hamilton Rating Scale for Depression. At the end of the study, plasma QTP levels were determined and examined in relation to clinical outcome and tolerability. Results: The mean scores of each rating scale were significantly lower at the end of the study in the population as a whole, and within each diagnostic group. The percentage improvement was significantly greater in the patients with drug-induced psychosis than in those with schizophrenia (42.4 ± 9.1% versus 23.6 ± 13.5%). QTP was well tolerated, and the incidence of extrapyramidal side effects was low. There was a linear correlation between plasma levels and dose/kg of QTP (r = 0.31; p < 0.05). The improvement in PANSS significantly correlated with plasma levels and dose/kg in each diagnostic category (Spearman's coefficient was 0.75 [p < 0.01] for schizophrenia and borderline personality disorder, and was 0.68 [p < 0.05] for drug-induced psychosis). Conclusion: The results suggest that 2 weeks' QTP treatment may improve the clinical outcome of psychotic re-exacerbation phases in different diagnostic categories and indicate that QTP improves clinical outcome in drug-induced psychosis, as QTP levels correlated with the clinical improvement measured by PANSS." @default.
- W2026351331 created "2016-06-24" @default.
- W2026351331 creator A5006732921 @default.
- W2026351331 creator A5013556761 @default.
- W2026351331 creator A5015648879 @default.
- W2026351331 creator A5056784482 @default.
- W2026351331 creator A5069907248 @default.
- W2026351331 date "2007-10-01" @default.
- W2026351331 modified "2023-09-27" @default.
- W2026351331 title "Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels" @default.
- W2026351331 cites W1821730900 @default.
- W2026351331 cites W1970892722 @default.
- W2026351331 cites W1974198858 @default.
- W2026351331 cites W1995760805 @default.
- W2026351331 cites W2013729634 @default.
- W2026351331 cites W2016677283 @default.
- W2026351331 cites W2019879674 @default.
- W2026351331 cites W2020844317 @default.
- W2026351331 cites W2022864353 @default.
- W2026351331 cites W2022932976 @default.
- W2026351331 cites W2025243014 @default.
- W2026351331 cites W2033468374 @default.
- W2026351331 cites W2040934031 @default.
- W2026351331 cites W2043038851 @default.
- W2026351331 cites W2045857358 @default.
- W2026351331 cites W2046815959 @default.
- W2026351331 cites W2057131927 @default.
- W2026351331 cites W2059190226 @default.
- W2026351331 cites W2060802427 @default.
- W2026351331 cites W2061432386 @default.
- W2026351331 cites W2066145518 @default.
- W2026351331 cites W2066482264 @default.
- W2026351331 cites W2089001892 @default.
- W2026351331 cites W2114613490 @default.
- W2026351331 cites W2118451279 @default.
- W2026351331 cites W2119369900 @default.
- W2026351331 cites W2126261598 @default.
- W2026351331 cites W2127126926 @default.
- W2026351331 cites W2127606597 @default.
- W2026351331 cites W2140606211 @default.
- W2026351331 cites W2154306952 @default.
- W2026351331 cites W2165379748 @default.
- W2026351331 cites W2171153453 @default.
- W2026351331 cites W2324877456 @default.
- W2026351331 cites W59829318 @default.
- W2026351331 doi "https://doi.org/10.1517/14656566.8.14.2207" @default.
- W2026351331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17927477" @default.
- W2026351331 hasPublicationYear "2007" @default.
- W2026351331 type Work @default.
- W2026351331 sameAs 2026351331 @default.
- W2026351331 citedByCount "31" @default.
- W2026351331 countsByYear W20263513312012 @default.
- W2026351331 countsByYear W20263513312013 @default.
- W2026351331 countsByYear W20263513312014 @default.
- W2026351331 countsByYear W20263513312015 @default.
- W2026351331 countsByYear W20263513312018 @default.
- W2026351331 countsByYear W20263513312021 @default.
- W2026351331 countsByYear W20263513312023 @default.
- W2026351331 crossrefType "journal-article" @default.
- W2026351331 hasAuthorship W2026351331A5006732921 @default.
- W2026351331 hasAuthorship W2026351331A5013556761 @default.
- W2026351331 hasAuthorship W2026351331A5015648879 @default.
- W2026351331 hasAuthorship W2026351331A5056784482 @default.
- W2026351331 hasAuthorship W2026351331A5069907248 @default.
- W2026351331 hasConcept C118552586 @default.
- W2026351331 hasConcept C126322002 @default.
- W2026351331 hasConcept C138496976 @default.
- W2026351331 hasConcept C15744967 @default.
- W2026351331 hasConcept C197934379 @default.
- W2026351331 hasConcept C2776412080 @default.
- W2026351331 hasConcept C2778375690 @default.
- W2026351331 hasConcept C2778528637 @default.
- W2026351331 hasConcept C2779727114 @default.
- W2026351331 hasConcept C2780135775 @default.
- W2026351331 hasConcept C2780200951 @default.
- W2026351331 hasConcept C2780600973 @default.
- W2026351331 hasConcept C2780634440 @default.
- W2026351331 hasConcept C2908647359 @default.
- W2026351331 hasConcept C71924100 @default.
- W2026351331 hasConcept C83849319 @default.
- W2026351331 hasConcept C99454951 @default.
- W2026351331 hasConceptScore W2026351331C118552586 @default.
- W2026351331 hasConceptScore W2026351331C126322002 @default.
- W2026351331 hasConceptScore W2026351331C138496976 @default.
- W2026351331 hasConceptScore W2026351331C15744967 @default.
- W2026351331 hasConceptScore W2026351331C197934379 @default.
- W2026351331 hasConceptScore W2026351331C2776412080 @default.
- W2026351331 hasConceptScore W2026351331C2778375690 @default.
- W2026351331 hasConceptScore W2026351331C2778528637 @default.
- W2026351331 hasConceptScore W2026351331C2779727114 @default.
- W2026351331 hasConceptScore W2026351331C2780135775 @default.
- W2026351331 hasConceptScore W2026351331C2780200951 @default.
- W2026351331 hasConceptScore W2026351331C2780600973 @default.
- W2026351331 hasConceptScore W2026351331C2780634440 @default.
- W2026351331 hasConceptScore W2026351331C2908647359 @default.
- W2026351331 hasConceptScore W2026351331C71924100 @default.
- W2026351331 hasConceptScore W2026351331C83849319 @default.
- W2026351331 hasConceptScore W2026351331C99454951 @default.